Immunotherapy of biliary tract cancer
- PMID: 26729196
- DOI: 10.1007/s13277-015-4743-x
Immunotherapy of biliary tract cancer
Abstract
Biliary tract cancers (BTCs), which encompass intra- and extrahepatic cholangiocarcinomas as well as gallbladder carcinomas, are one of the most aggressive malignancies. Although the development of systemic chemotherapy approaches has made progress, the prognosis of BTC remains poor. Chronic inflammation plays an important role in the carcinogenesis of BTC, highlighting the immune etiology of this disease. Immunotherapy has emerged as a promising new modality of treatment for BTC. Here, we summarize the relevant tumor immunology of BTC and recently completed and ongoing clinical trials of immunotherapy for BTC.
Keywords: Biliary tract cancer; Cholangiocarcinoma; Immunotherapy.
Similar articles
-
Immunotherapeutic Approaches to Biliary Cancer.Curr Treat Options Oncol. 2017 Jul;18(7):44. doi: 10.1007/s11864-017-0486-9. Curr Treat Options Oncol. 2017. PMID: 28660602 Review.
-
Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.Curr Probl Cancer. 2018 Jan-Feb;42(1):49-58. doi: 10.1016/j.currproblcancer.2017.10.004. Epub 2017 Oct 31. Curr Probl Cancer. 2018. PMID: 29501212 Free PMC article. Review.
-
Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers.Int J Med Sci. 2023 May 11;20(7):858-869. doi: 10.7150/ijms.82008. eCollection 2023. Int J Med Sci. 2023. PMID: 37324191 Free PMC article. Review.
-
The present and the future of immunotherapy in hepatocellular carcinoma and biliary tract cancers.Cancer Treat Rev. 2025 Jun;137:102955. doi: 10.1016/j.ctrv.2025.102955. Epub 2025 May 9. Cancer Treat Rev. 2025. PMID: 40373702 Review.
-
The role of novel biologics in biliary cancers.Minerva Gastroenterol Dietol. 2016 Dec;62(4):325-339. Epub 2016 Aug 31. Minerva Gastroenterol Dietol. 2016. PMID: 27576672 Review.
Cited by
-
Horizons on the Therapy of Biliary Tract Cancers: A State-of-the-art Review.J Clin Transl Hepatol. 2021 Aug 28;9(4):559-567. doi: 10.14218/JCTH.2021.00007. Epub 2021 May 12. J Clin Transl Hepatol. 2021. PMID: 34447686 Free PMC article. Review.
-
Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and Its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-oncology.Cancer Res Treat. 2019 Apr;51(2):832-840. doi: 10.4143/crt.2018.311. Epub 2018 Oct 5. Cancer Res Treat. 2019. PMID: 30309223 Free PMC article.
-
Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma.Sci Rep. 2021 Jun 3;11(1):11743. doi: 10.1038/s41598-021-89977-9. Sci Rep. 2021. PMID: 34083572 Free PMC article.
-
Response of cholangiocarcinoma with epigastric metastasis to lenvatinib plus sintilimab: A case report and review of literature.World J Gastrointest Oncol. 2023 Nov 15;15(11):2033-2040. doi: 10.4251/wjgo.v15.i11.2033. World J Gastrointest Oncol. 2023. PMID: 38077645 Free PMC article.
-
High CD8+ and absence of Foxp3+ T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival.BMC Cancer. 2018 Mar 2;18(1):243. doi: 10.1186/s12885-018-4147-6. BMC Cancer. 2018. PMID: 29499656 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials